Florida 2022 Regular Session

Florida House Bill H0731

Introduced
11/24/21  
Refer
12/13/21  
Refer
12/13/21  
Refer
12/13/21  

Caption

Drug-related Overdose Prevention

Impact

If passed, HB 731 will have a significant impact on public health laws in Florida, particularly in how medical professionals engage with patients at risk for opioid overdoses. The requirement for hospitals and urgent care centers to report incidents of opioid overdoses to the Department of Health promotes better tracking and response strategies. Such measures are essential in addressing the ongoing public health crisis related to opioid misuse and overdoses in the state.

Summary

House Bill 731, concerning drug-related overdose prevention, aims to amend existing Florida statutes related to the prescribing, ordering, and dispensing of emergency opioid antagonists. The bill expands the roles of authorized healthcare practitioners—including pharmacists—by allowing them to prescribe and dispense these life-saving medications to patients and caregivers. It also grants immunity from civil or criminal liability to individuals administering these antagonists under specific circumstances, which is crucial given the urgency of overdose response scenarios.

Sentiment

The sentiment around the bill appears largely supportive, especially from healthcare professionals who recognize the necessity of swift intervention in overdose cases. Advocacy groups focused on substance abuse prevention also endorse the bill as a means to enhance community safety and health awareness. However, some concerns linger regarding the balance between adequate training for non-medical responders and the potential misuse of opioids, warranting careful considerations in the implementation of these new laws.

Contention

One notable point of contention involves the broad authority granted to a variety of agency personnel—including law enforcement and public health officials—regarding the administration of emergency opioid antagonists. While this approach aims to streamline response efforts during crises, some critics argue that it may lead to inappropriate use without adequate medical oversight. As the bill proposes changes to multiple existing statutes, discussions about accountability and risk management will be essential in navigating its legislative journey.

Companion Bills

FL S0544

Same As Drug-related Overdose Prevention

Similar Bills

CA AB2256

Law enforcement agencies: opioid antagonist.

CA AB24

Emergency response: opioid antagonist kits.

HI HB310

Relating To Opioid Antagonists.

CA SB234

Opioid antagonists: stadiums, concert venues, and amusement parks.

CA AB1166

Liability for opioid antagonist administration.

CA SB472

Pupil health: opioid overdose reversal medication.

MI HB5077

Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for. Amends title & secs. 103 & 107 of 2019 PA 39 (MCL 15.673 & 15.677) & adds sec. 106.

MI HB4366

Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for. Amends title & secs. 103 & 107 of 2019 PA 39 (MCL 15.673 & 15.677) & adds sec. 106. TIE BAR WITH: HB 4365'23